[1]
Dr. Banupriya B and Dr. Nandhidha R 2024. EVALUATION OF SAFETY AND EFFICACY OF DAPAGLIFLOZIN AS FIRST LINE MONOTHERAPY WITH METFORMIN IN PATIENTS WITH NEWLY DIAGNOSED TYPE 2 DIABETES MELLITUS - A RANDOMIZED OPEN LABEL STUDY. Journal of Population Therapeutics and Clinical Pharmacology. 31, 8 (Aug. 2024), 1625–1635. DOI:https://doi.org/10.53555/p37cha52.